Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumour tissues…
Browsing: GU Cancers
ASCO 2020: Immunotherapy following chemotherapy offers extended survival to patients with advanced urothelial cancer
Treatment with avelumab combined with best supportive care following chemotherapy significantly extended overall survival compared…
Dire shortage of BCG impacts treatment of bladder cancer patients
Leading Australian urologist Professor Dickon Hayne has been one of the many health professionals happy…
Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer
A clinical trial led by Mount Sinai researchers in the US has showed for the…
Innovative approach offers option for treating upper tract urothelial cancer
Treatment of low-grade upper tract urothelial cancer usually involves radical surgery to remove the kidney…
New ‘toolbox’ for urological cancer detection
Researchers from Ghent University, Belgium, together with researchers from the University of Turku, Finland, have…
FDA approves mitomycin for low-grade upper tract urothelial cancer
The Food and Drug Administration (FDA) approved mitomycin for adult patients with low-grade upper tract…
Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the…
E-cigarette users had substances linked to bladder cancer in urine
An analysis of evidence from multiple scientific studies found six substances that have a strong…
Adding chemotherapy to radiotherapy for bladder cancer shows benefits for patients
Data from a clinical trial which assessed the benefits of adding chemotherapy alongside radiotherapy for…